ADVFN - ニュース

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/11	05 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SBAC	SBA Communications Corporation
2024/07/11	05 : 53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NVDA	NVIDIA Corporation
2024/07/11	05 : 50	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CBAT	CBAK Energy Technology Inc
2024/07/11	05 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCYC	Bicycle Therapeutics PLC
2024/07/11	05 : 50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CPA	Copa Holdings SA
2024/07/11	05 : 50	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:GEO	Geo Group Inc New
2024/07/11	05 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SMSI	Smith Micro Software Inc
2024/07/11	05 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AB	AllianceBernstein Holding LP
2024/07/11	05 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HBI	Hanesbrands Inc
2024/07/11	05 : 48	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:TNON	Tenon Medical Inc
2024/07/11	05 : 48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/07/11	05 : 48	Business Wire	Walgreens Boots Alliance Declares Quarterly Dividend	NASDAQ:WBA	Walgreens Boots Alliance Inc
2024/07/11	05 : 47	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/11	05 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/07/11	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SMSI	Smith Micro Software Inc
2024/07/11	05 : 47	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INKI	Inky Inc (PK)
2024/07/11	05 : 47	PR Newswire (US)	COPA HOLDINGS ANNOUNCES MONTHLY TRAFFIC STATISTICS FOR JUNE 2024	NYSE:CPA	Copa Holdings SA
2024/07/11	05 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VCTR	Victory Capital Holdings Inc
2024/07/11	05 : 46	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:BML-L	Bank of America Corporation
2024/07/11	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SKIN	Beauth Health Company
2024/07/11	05 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LPG	Dorian LPG Ltd
2024/07/11	05 : 46	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:ENVA	Enova International Inc
2024/07/11	05 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:APD	Air Products and Chemicals Inc
2024/07/11	05 : 46	GlobeNewswire Inc.	Animal Welfare, Conservation Groups Announce Lawsuit Against U.S. Fish & Wildlife For Failure to Protect Gray Wolves
2024/07/11	05 : 46	Business Wire	Angels for Change Goes ALL IN on Ending Drug Shortages with Fifth Annual SummitONE Conference
2024/07/11	05 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/11	05 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RGS	Regis Corp
2024/07/11	05 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IAS	Intergral Ad Science Holding Corporation
2024/07/11	05 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DERM	Journey Medical Corporation
2024/07/11	05 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OLK	Olink Holding AB

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

American Express

Bank of America

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約